Both in Pharmaceuticals
Immunome vs Aurinia Pharmaceuticals
Over the past year IMNM returned +14.3% and AUPH returned +37.5%; their daily moves had a correlation of 0.20.
IMNM +14.3% AUPH +37.5%Growth of $1, one year, split-adjusted
| Metric | IMNM | AUPH |
|---|---|---|
| Price | $18.01 | $16.80 |
| Market cap | $2.13B | $2.24B |
| Today | −1.53% | −2.38% |
| 1 month | −13.8% | +5.3% |
| 6 months | −20.8% | +9.4% |
| Year to date | −16.2% | +5.3% |
| 1 year | +14.3% | +37.5% |
| Revenue growth (YoY) | −100.0% | +18.9% |
| Gross margin | — | 92.1% |
| Net margin | — | 45.0% |
| P/E (TTM) | — | 7.1× |
| Price / sales | — | 7.2× |
| Net cash | $520.0M | $382.7M |
| Dividend yield | — | — |
| Volatility (60d) | 55.6% | 29.5% |
| Short % of float | 17.1% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).